Leukemia – Phase 1 clinical trial of B-Cell Maturation Antigen (BCMA) NEX-T® Chimeric Antigen Receptor (CAR) T cell therapy CC-98633/BMS-986354 in participants with triple-class exposed…
Nature Reviews Genetics – Collins and Talkowski provide a broad overview of structural variation in the human genome that covers their mutational properties, the dynamics…
Issue 156: An interview with Revolutionary Evan Mawarire about his new book “Crazy Epic Courage” on how he started a revaluation in Zimbabwe
Nature – A phase I trial of a neoantigen-targeting personalized cancer vaccine led to durable and polyfunctional T cell responses and antitumour recognition, and was…
By Mahmoud Marashi, Khalil Al Farsi & 8 more. Treatment options for newly diagnosed multiple myeloma (NDMM) have expanded dramatically over the last two decades,…
Professor of primary care and public health Azeem Majeed talks to Carla Delgado about his passion for tackling health inequalities through data As a medical…
Speaker: Gili Kenet Prof. Gili Kenet is a Pediatric Hematologist, Professor and chair of the Haematology department at the Sackler Medical School, Tel Aviv University,…
Attorneys general sued the Trump administration to block a NIH decision that would slash grant payments for research overhead
The myelodysplastic syndromes (MDS) are a heterogenous group of clonal bone marrow (BM) stem cell myeloid neoplasms, characterized by BM dysplasia, macrocytic anemia or cytopenia…
“What we’ve done is create an instrument where your hands don’t need to be inside the body,” said Dr. David Wazer. “It can be done…
Small-cell lung cancer (SCLC) has limited second-line treatment options after chemotherapy. We assessed the efficacy and safety of lurbinectedin combined with pembrolizumab in relapsed SCLC…
